Candesartan Cilexetil
22 NDCs across 4 manufacturers|17 Generic,5 Brand
Candesartan Cilexetil is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 4, 1998, and the first generic was approved May 3, 2013. FDA's Orange Book lists 23 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $42 million on Candesartan Cilexetil across 497,000 claims for 121,000 beneficiaries.
Candesartan Cilexetil is available as 22 NDCs from 4 manufacturers (17 generic, 5 brand), with NADAC prices from $0.48 to $9.90 per EA — the most expensive product costs about 21× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
22
17G / 5B
Manufacturers
4
competing in market
Price Spread
$0.48 – $9.90
per EA
7d Activity
avg +0.5% WoW · of 22 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Alembic Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin 2 Receptor Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing CANDESARTAN CILEXETIL
Frequently Asked Questions
What is Candesartan Cilexetil used to treat?
Candesartan Cilexetil is used to treat diabetic nephropathies, heart failure, hypertension and left ventricular dysfunction, per the National Library of Medicine's MED-RT classification.
When did Candesartan Cilexetil become available as a generic?
FDA approved the first generic Candesartan Cilexetil (ANDA) on May 3, 2013. The Orange Book currently lists 23 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Candesartan Cilexetil?
In 2024, Medicare Part D spent $42 million on Candesartan Cilexetil across 497,000 claims for 121,000 beneficiaries.
How many Candesartan Cilexetil products are on the market?
The Candesartan Cilexetil drug market contains 22 NDCs from 4 manufacturers — 17 generic and 5 brand products.
What is the price range for Candesartan Cilexetil?
NADAC reference prices for Candesartan Cilexetil range from $0.4784 to $9.9038 per EA — the most expensive product costs about 21× the cheapest.
Is generic Candesartan Cilexetil cheaper than brand?
The average generic NADAC for Candesartan Cilexetil is $0.5276 per EA, versus $8.5446 for brand-labeled products — brand versions average about 16× the generic price.
Which manufacturers make Candesartan Cilexetil?
4 manufacturers list Candesartan Cilexetil in NADAC. Ranked by number of NDCs, the largest are Alembic Pharmaceuticals Inc. (8), Mylan Pharmaceuticals Inc. (8), ANI Pharmaceuticals, Inc. (5), Par Pharmaceutical Inc. (1).
How has the price of Candesartan Cilexetil changed recently?
Over the past 7 days, 10 Candesartan Cilexetil NDCs rose and 8 fell, with a market-wide average change of +0.5%.